Myasthenia Gravis (MG) Treatment Industry Forecast to 2030: A $2.5 Billion Market Dominated by Alexion Pharma, Grifols, Avadel Pharma, Novartis, Pfizer, AbbVie, and Roche
April 17, 2024 04:05 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva
December 18, 2023 06:43 ET
|
Research and Markets
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering. The global market for...
Myasthenia Gravis Treatment Market Size, Share & Growth Analysis, [2028] | With CAGR of 7.5%
December 06, 2023 07:28 ET
|
Fortune Business Insights
Pune, India, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Global Myasthenia Gravis Treatment Market Size was valued at USD 1.15 billion in 2020 and is projected to grow from USD 2.03 billion by 2028 exhibiting...
Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst, Cabaletta Bio, Janssen, Argenx, UCB Pharma, Alexion, Immunovant
October 25, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst,...
Myasthenia Gravis Treatment Market is forecasted to reach USD 2.6 Billion by 2032, growing at a 7.3% CAGR from 2023 to 2032
October 03, 2023 11:12 ET
|
Acumen Research and Consulting
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The Global Myasthenia Gravis Treatment Market Size accounted for USD 1.3 Billion in 2022 and is projected to achieve a market size of USD 2.6 Billion...
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
May 15, 2023 21:00 ET
|
Allied Market Research
Portland, OR, May 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Myasthenia Gravis Treatment Market by Drug class (Monoclonal antibodies, Intravenous...
Myasthenia Gravis Treatment Market Size [2022-2029]: $2.03 Billion by 2028 at CAGR of 7.5%
May 26, 2022 06:26 ET
|
Fortune Business Insights
Pune, India, May 26, 2022 (GLOBE NEWSWIRE) -- The global myasthenia gravis treatment market size is anticipated to reach USD 2.03 billion by 2028 and exhibit a CAGR of 7.5% during the forecast...
Myasthenia Gravis Treatment Market Size [2022-2028] worth USD 2.03 billion | Exhibit a CAGR of 7.5%
February 28, 2022 08:14 ET
|
Fortune Business Insights
Pune, India, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The global myasthenia gravis treatment market size is anticipated to reach USD 2.03 billion by 2028 and exhibit a CAGR of 7.5% during the forecast...
Recent Clinical Trials Analysis on Myasthenia Gravis Treatment
July 22, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, July 22, 2021 (GLOBE NEWSWIRE) -- Recent Clinical Trials Analysis on Myasthenia Gravis Treatment Around 15+ key companies are developing the Myasthenia Gravis therapies. Argenx...